170 related articles for article (PubMed ID: 32439945)
1. Vaccine adjuvant activity of a TLR4-activating synthetic glycolipid by promoting autophagy.
Chou YJ; Lin CC; Dzhagalov I; Chen NJ; Lin CH; Lin CC; Chen ST; Chen KH; Fu SL
Sci Rep; 2020 May; 10(1):8422. PubMed ID: 32439945
[TBL] [Abstract][Full Text] [Related]
2. In vitro and in vivo anticancer activity of a synthetic glycolipid as Toll-like receptor 4 (TLR4) activator.
Lin YS; Huang LD; Lin CH; Huang PH; Chen YJ; Wong FH; Lin CC; Fu SL
J Biol Chem; 2011 Dec; 286(51):43782-43792. PubMed ID: 21949133
[TBL] [Abstract][Full Text] [Related]
3. CCL-34, a synthetic toll-like receptor 4 activator, modulates differentiation and maturation of myeloid dendritic cells.
Fu SL; Lin CC; Hsu ML; Liu SH; Huang YC; Chen YJ
Oncotarget; 2016 Mar; 7(10):11677-86. PubMed ID: 26883191
[TBL] [Abstract][Full Text] [Related]
4. A synthetic analog of alpha-galactosylceramide induces macrophage activation via the TLR4-signaling pathways.
Hung LC; Lin CC; Hung SK; Wu BC; Jan MD; Liou SH; Fu SL
Biochem Pharmacol; 2007 Jun; 73(12):1957-70. PubMed ID: 17445776
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide from Phellinus Igniarius activates TLR4-mediated signaling pathways in macrophages and shows immune adjuvant activity in mice.
Wang YQ; Mao JB; Zhou MQ; Jin YW; Lou CH; Dong Y; Shou D; Hu Y; Yang B; Jin CY; Shi HC; Zhao HJ; Wen CP
Int J Biol Macromol; 2019 Feb; 123():157-166. PubMed ID: 30439422
[TBL] [Abstract][Full Text] [Related]
6. Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses.
Seydoux E; Liang H; Dubois Cauwelaert N; Archer M; Rintala ND; Kramer R; Carter D; Fox CB; Orr MT
J Immunol; 2018 Jul; 201(1):98-112. PubMed ID: 29769270
[TBL] [Abstract][Full Text] [Related]
7. Funiculosin variants and phosphorylated derivatives promote innate immune responses via the Toll-like receptor 4/myeloid differentiation factor-2 complex.
Okamoto N; Mizote K; Honda H; Saeki A; Watanabe Y; Yamaguchi-Miyamoto T; Fukui R; Tanimura N; Motoi Y; Akashi-Takamura S; Kato T; Fujishita S; Kimura T; Ohto U; Shimizu T; Hirokawa T; Miyake K; Fukase K; Fujimoto Y; Nagai Y; Takatsu K
J Biol Chem; 2017 Sep; 292(37):15378-15394. PubMed ID: 28754693
[TBL] [Abstract][Full Text] [Related]
8. Induction of autophagy through CLEC4E in combination with TLR4: an innovative strategy to restrict the survival of
Pahari S; Negi S; Aqdas M; Arnett E; Schlesinger LS; Agrewala JN
Autophagy; 2020 Jun; 16(6):1021-1043. PubMed ID: 31462144
[TBL] [Abstract][Full Text] [Related]
9. SYK regulates macrophage MHC-II expression via activation of autophagy in response to oxidized LDL.
Choi SH; Gonen A; Diehl CJ; Kim J; Almazan F; Witztum JL; Miller YI
Autophagy; 2015; 11(5):785-95. PubMed ID: 25946330
[TBL] [Abstract][Full Text] [Related]
10. Adjuvanting a Simian Immunodeficiency Virus Vaccine with Toll-Like Receptor Ligands Encapsulated in Nanoparticles Induces Persistent Antibody Responses and Enhanced Protection in TRIM5α Restrictive Macaques.
Kasturi SP; Kozlowski PA; Nakaya HI; Burger MC; Russo P; Pham M; Kovalenkov Y; Silveira ELV; Havenar-Daughton C; Burton SL; Kilgore KM; Johnson MJ; Nabi R; Legere T; Sher ZJ; Chen X; Amara RR; Hunter E; Bosinger SE; Spearman P; Crotty S; Villinger F; Derdeyn CA; Wrammert J; Pulendran B
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928002
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
12. An agonistic anti-Toll-like receptor 4 monoclonal antibody as an effective adjuvant for cancer immunotherapy.
Tsukamoto H; Kubota K; Shichiku A; Maekawa M; Mano N; Yagita H; Ohta S; Tomioka Y
Immunology; 2019 Oct; 158(2):136-149. PubMed ID: 31515801
[TBL] [Abstract][Full Text] [Related]
13. Activated toll-like receptor 4 is involved in oridonin-induced phagocytosis via promotion of migration and autophagy-lysosome pathway in RAW264.7 macrophages.
Zang L; Wang J; Ren Y; Liu W; Yu Y; Zhao S; Otkur W; Zhao Y; Hayashi T; Tashiro SI; Onodera S; Ikejima T
Int Immunopharmacol; 2019 Jan; 66():99-108. PubMed ID: 30445312
[TBL] [Abstract][Full Text] [Related]
14. The differences in immunoadjuvant mechanisms of TLR3 and TLR4 agonists on the level of antigen-presenting cells during immunization with recombinant adenovirus vector.
Lebedeva E; Bagaev A; Pichugin A; Chulkina M; Lysenko A; Tutykhina I; Shmarov M; Logunov D; Naroditsky B; Ataullakhanov R
BMC Immunol; 2018 Jul; 19(1):26. PubMed ID: 30055563
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant use of the NKT cell agonist alpha-galactosylceramide leads to enhancement of M2-based DNA vaccine immunogenicity and protective immunity against influenza A virus.
Fotouhi F; Shaffifar M; Farahmand B; Shirian S; Saeidi M; Tabarraei A; Gorji A; Ghaemi A
Arch Virol; 2017 May; 162(5):1251-1260. PubMed ID: 28120096
[TBL] [Abstract][Full Text] [Related]
16. Toll-like receptor ligands directly promote activated CD4+ T cell survival.
Gelman AE; Zhang J; Choi Y; Turka LA
J Immunol; 2004 May; 172(10):6065-73. PubMed ID: 15128790
[TBL] [Abstract][Full Text] [Related]
17. Ginsenosides Rg1 and Re act as adjuvant via TLR4 signaling pathway.
Su F; Yuan L; Zhang L; Hu S
Vaccine; 2012 Jun; 30(27):4106-12. PubMed ID: 22472794
[TBL] [Abstract][Full Text] [Related]
18. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells.
Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X
PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536
[TBL] [Abstract][Full Text] [Related]
19. Artesunate Attenuates Pro-Inflammatory Cytokine Release from Macrophages by Inhibiting TLR4-Mediated Autophagic Activation via the TRAF6-Beclin1-PI3KC3 Pathway.
Kuang M; Cen Y; Qin R; Shang S; Zhai Z; Liu C; Pan X; Zhou H
Cell Physiol Biochem; 2018; 47(2):475-488. PubMed ID: 29794440
[TBL] [Abstract][Full Text] [Related]
20. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.
Heldwein KA; Liang MD; Andresen TK; Thomas KE; Marty AM; Cuesta N; Vogel SN; Fenton MJ
J Leukoc Biol; 2003 Aug; 74(2):277-86. PubMed ID: 12885945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
